e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

UroGen Pharma Ltd. - Ordinary Shares (NQ:URGN)

18.44 -0.35 (-1.86%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about UroGen Pharma Ltd. - Ordinary Shares

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stocks That Hit 52-Week Lows On Thursday ↗

August 19, 2021

Thursday morning, 173 companies reached new 52-week lows. Areas of Interest: The largest company by market cap to set a new 52-week low was Alibaba Group Holding (...

Via Benzinga

UroGen Pharma Reports Second Quarter 2021 Financial Results and Recent Corporate Developments

August 04, 2021

From UroGen Pharma Ltd.

Via Business Wire

UroGen Pharma Announces License and Supply Agreement with Neopharm to Pursue Regulatory Approval and Commercialization for Jelmyto® in Israel

July 28, 2021

From UroGen Pharma Ltd.

Via Business Wire

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

Earnings Scheduled For August 4, 2021 ↗

August 04, 2021

Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter. • Vericel (NASDAQ:VCEL) is expected to...

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs ↗

July 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

UroGen Pharma to Report Second Quarter 2021 Financial Results on Wednesday, August 4, 2021

July 28, 2021

From UroGen Pharma Ltd.

Via Business Wire

UroGen Pharma Reports Strong Preliminary Jelmyto® Sales for Second Quarter 2021

July 14, 2021

From UroGen Pharma Ltd.

Via Business Wire

Stocks That Hit 52-Week Lows On Monday ↗

July 12, 2021

On Monday morning, 16 companies achieved new lows for the year. Points of Interest: The largest company in terms of market cap to set a new 52-week low was Tencent...

Via Benzinga

UroGen Pharma to Present at Ladenburg Thalmann Healthcare Conference

July 07, 2021

From UroGen Pharma Ltd

Via Business Wire

The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data ↗

July 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

UroGen Pharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 04, 2021

From UroGen Pharma Ltd.

Via Business Wire

UroGen Pharma Announces June 2021 Conference Schedule

May 25, 2021

From UroGen Pharma Ltd.

Via Business Wire

Looking Into UroGen Pharma's Return On Capital Employed ↗

May 21, 2021

UroGen Pharma (NASDAQ:URGN) reported Q1 sales of $7.49 million. Earnings fell to a loss of $26.11 million, resulting in a 4.18% decrease from last quarter. In Q4, UroGen Pharma...

Via Benzinga

77 Biggest Movers From Yesterday ↗

May 14, 2021

Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) shares surged 23.7% to close at $12.77. Moxian, Inc. (NASDAQ: MOXC) jumped 23.6% to close at $9.52. Repro Med Systems, Inc...

Via Benzinga

The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts ↗

May 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc...

Via Benzinga

44 Stocks Moving In Thursday's Mid-Day Session ↗

May 13, 2021

Gainers Reliance Global Group, Inc. (NASDAQ: RELI) jumped 38.7% to $4.0901 after the company said it has acquired a premier health insurance agency, J.P. Kush and Associates, Inc...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

May 13, 2021

During Thursday's morning session, 24 stocks hit new 52-week lows. Facts of Interest: American Well (NYSE:AMWL) was the largest firm by market cap to set a new...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use ↗

May 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc...

Via Benzinga

UroGen Pharma Reports First Quarter 2021 Financial Results and Recent Corporate Developments

May 13, 2021

From UroGen Pharma Ltd.

Via Business Wire

UroGen Pharma to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021

May 06, 2021

From UroGen Pharma Ltd.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

April 13, 2021

Tuesday morning, 38 companies set new 52-week lows. Key Facts: Viatris (NASDAQ:VTRS) was the largest company by market cap to set a new 52-week low. Enservco (AMEX:...

Via Benzinga

Earnings Scheduled For May 13, 2021 ↗

May 13, 2021

Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. •...

Via Benzinga

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗

May 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...

Via Benzinga

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy